Tenofovir Alafenamide (Vemlidy)

SELF ADMINISTRATION - ORAL

Indications for Prior Authorization:

  • Treatment of chronic hepatitis B (HBV) infection in adults with compensated liver disease

Patients must meet the following criteria for the indication(s) above:

  • Prescribed by or in collaboration with a specialist; AND

  • Diagnosis of chronic HBV in adults with compensated liver disease; AND
  • First line agent (i.e., Viread) has been tried and failed or documented reason why it cannot be considered (documented renal or bone impairment, or those at high risk (e.g.postmenopausal women)); AND
  • Use is not recommended in those with CrCl < 15mL/minute or if Child-Pugh class B or C
  • Hepatic enzymes, ALT and AST, should be monitored during therapy
  • HIV testing: HIV antibody testing should be offered to all HBV infected patients prior to treatment initiation
  • HIV and HBV coinfection: Should not be used as a single agent for the treatment of HIV due to resistance development risk
  • For females: There have been no data reported to the antiretrovial registry related to the use of this drug in pregnancy.  The Health and Human Services (HHS) Perinatal HIV Guidelines note data are insufficient to recommend tenofovir alafenamide for initial therapy in antiretrovial-naive pregnant women 

The following conditions do not meet the criteria for use as established by WHA P&T committee:

  • all non-FDA approved uses not listed in the approved indications

Dosing:

  • 25mg orally once daily with food

Approval:

  • 1 year

Last review date: March 22, 2017

The site you are transferring to is not hosted by WHA. WHA's Terms of Use and internet Privacy Practices do not apply to your use of this linked site. Please review the policies on privacy and terms of use for the linked site. WHA does not control the accuracy, completeness, or timeliness of the content on the linked site.

Press Esc to cancel

El sitio Web al que está siendo transferido no es provisto por WHA. Las Condiciones de Uso y las Prácticas de Privacidad en Internet de WHA no se aplican a este sitio Web asociado que usted está usando. Revise las políticas sobre la privacidad y condiciones de uso de este sitio Web asociado. WHA no tiene control sobre la exactitud, la totalidad o la actualidad del contenido del sitio Web asociado. WHA no puede garantizar que los servicios de traducción de idiomas estarán disponibles en el sitio vinculado.

Presione «Esc» para cancelar